OncoMatch/Clinical Trials/NCT04723810
TumorGlow Intraoperative Molecular Imaging (IMI)
Is NCT04723810 recruiting? Yes, currently enrolling (May 2026). This Phase 1/2 trial studies Indocyanine Green for tumor, solid.
Treatment: Indocyanine Green — This is a Phase 1/2 study in patients presenting with any solid tumor and/or diseased tissue even benign nodules presumed to be resectable and at risk for recurrence on pre-operative assessment who are considered to be good surgical candidates to evaluate the safety and efficacy of the image-guided surgery using indocyanine green for intramolecular imaging of solid tumors.
Check if I qualifyEligibility summary
For patients with solid tumor.
This summary was generated by AI from the trial's official eligibility criteria and may contain errors. Always confirm with the study team before contacting a site.
US trial sites
- University of Pennsylvania · Philadelphia, Pennsylvania
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify